CD4+ CD25+ regulatory T cells: a therapeutic target for liver diseases. (Q37082777)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18269341%20AND%20SRC:MED&resulttype=core&format=json

2 January 2020

review article

1 reference

title

CD4+ CD25+ regulatory T cells: a therapeutic target for liver diseases (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18269341%20AND%20SRC:MED&resulttype=core&format=json

2 January 2020

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18269341%20AND%20SRC:MED&resulttype=core&format=json

2 January 2020

Yuewen Gong

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18269341%20AND%20SRC:MED&resulttype=core&format=json

2 January 2020

author name string

Dian-Na Gu

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18269341%20AND%20SRC:MED&resulttype=core&format=json

2 January 2020

Martin Braddock

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18269341%20AND%20SRC:MED&resulttype=core&format=json

2 January 2020

Andrew J Leishman

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18269341%20AND%20SRC:MED&resulttype=core&format=json

2 January 2020

Chang Jin

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18269341%20AND%20SRC:MED&resulttype=core&format=json

2 January 2020

Jin-Sheng Wen

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18269341%20AND%20SRC:MED&resulttype=core&format=json

2 January 2020

Yong-Ping Chen

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18269341%20AND%20SRC:MED&resulttype=core&format=json

2 January 2020

language of work or name

English

0 references

publication date

1 March 2008

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18269341%20AND%20SRC:MED&resulttype=core&format=json

Expert Opinion on Therapeutic Targets

2 January 2020

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18269341%20AND%20SRC:MED&resulttype=core&format=json

2 January 2020

volume

12

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18269341%20AND%20SRC:MED&resulttype=core&format=json

2 January 2020

issue

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18269341%20AND%20SRC:MED&resulttype=core&format=json

2 January 2020

page(s)

313-326

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18269341%20AND%20SRC:MED&resulttype=core&format=json

Central tolerance of T cells

2 January 2020

cites work

1 reference

https://api.crossref.org/works/10.1517%2F14728222.12.3.313

Regulatory T cells in autoimmmunity*.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.12.3.313

Regulatory T cells in the control of immune pathology.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.12.3.313

Regulatory T cells under scrutiny

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.12.3.313

The role of different subsets of T regulatory cells in controlling autoimmunity

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.12.3.313

Interleukin-10 induces a long-term antigen-specific anergic state in human CD4+ T cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.12.3.313

Naturally arising Foxp3-expressing CD25+CD4+ regulatory T cells in immunological tolerance to self and non-self

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.12.3.313

Natural versus adaptive regulatory T cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.12.3.313

Type 1 T regulatory cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.12.3.313

Potential role of interleukin-10-secreting regulatory T cells in allergy and asthma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.12.3.313

Transforming growth factor-beta in T-cell biology

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.12.3.313

Human CD25+ regulatory T cells: two subsets defined by the integrins alpha 4 beta 7 or alpha 4 beta 1 confer distinct suppressive properties upon CD4+ T helper cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.12.3.313

Differentiation of Tr1 cells by immature dendritic cells requires IL-10 but not CD25+CD4+ Tr cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.12.3.313

IL-10-secreting regulatory T cells do not express Foxp3 but have comparable regulatory function to naturally occurring CD4+CD25+ regulatory T cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.12.3.313

CD4 T helper type 1 and regulatory T cells induced against the same epitopes on the core protein in hepatitis C virus-infected persons

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.12.3.313

A dominant function for interleukin 27 in generating interleukin 10-producing anti-inflammatory T cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.12.3.313

Impairment of CD4(+)CD25(+) regulatory T-cells in autoimmune liver disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.12.3.313

Effect of CD4+ CD25+ regulatory T-cells on CD8 T-cell function in patients with autoimmune hepatitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.12.3.313

T cells with a CD4+CD25+ regulatory phenotype suppress in vitro proliferation of virus-specific CD8+ T cells during chronic hepatitis C virus infection.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.12.3.313

Modulation of the CD8+-T-cell response by CD4+ CD25+ regulatory T cells in patients with hepatitis B virus infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.12.3.313

Regulatory T cells contribute to the impaired immune response in patients with chronic hepatitis B virus infection.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.12.3.313

An immunomodulatory role for CD4(+)CD25(+) regulatory T lymphocytes in hepatitis C virus infection.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.12.3.313

Increased populations of regulatory T cells in peripheral blood of patients with hepatocellular carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.12.3.313

Increase of CD4+ CD25+ regulatory T-cells in the liver of patients with hepatocellular carcinoma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.12.3.313

Control of regulatory T cell development by the transcription factor Foxp3

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.12.3.313

Foxp3 programs the development and function of CD4+CD25+ regulatory T cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.12.3.313

Disruption of a new forkhead/winged-helix protein, scurfin, results in the fatal lymphoproliferative disorder of the scurfy mouse

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.12.3.313

X-linked neonatal diabetes mellitus, enteropathy and endocrinopathy syndrome is the human equivalent of mouse scurfy

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.12.3.313

Clinical and molecular features of the immunodysregulation, polyendocrinopathy, enteropathy, X linked (IPEX) syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.12.3.313

Induction of FoxP3 and acquisition of T regulatory activity by stimulated human CD4+CD25– T cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.12.3.313

Expression of FOXP3 mRNA is not confined to CD4+CD25+ T regulatory cells in humans.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.12.3.313

A new member of the immunoglobulin superfamily--CTLA-4

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.12.3.313

Immunologic self-tolerance maintained by CD25(+)CD4(+) regulatory T cells constitutively expressing cytotoxic T lymphocyte-associated antigen 4.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.12.3.313

GITR, a member of the TNF receptor superfamily, is costimulatory to mouse T lymphocyte subpopulations

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.12.3.313

Mouse glucocorticoid-induced tumor necrosis factor receptor ligand is costimulatory for T cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.12.3.313

Engagement of glucocorticoid-induced TNFR family-related receptor on effector T cells by its ligand mediates resistance to suppression by CD4+CD25+ T cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.12.3.313

Expression of interleukin (IL)-2 and IL-7 receptors discriminates between human regulatory and activated T cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.12.3.313

CD127 expression inversely correlates with FoxP3 and suppressive function of human CD4+ T reg cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.12.3.313

Mechanisms of suppression by suppressor T cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.12.3.313

CD4+CD25+ immunoregulatory T cells suppress polyclonal T cell activation in vitro by inhibiting interleukin 2 production

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.12.3.313

Cutting edge: IL-2 is critically required for the in vitro activation of CD4+CD25+ T cell suppressor function

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.12.3.313

Interleukin-2 is essential for CD4+CD25+ regulatory T cell function

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.12.3.313

Development and function of T cells in mice rendered interleukin-2 deficient by gene targeting

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.12.3.313

Engagement of B7 on effector T cells by regulatory T cells prevents autoimmune disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.12.3.313

Modulation of tryptophan catabolism by regulatory T cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.12.3.313

IDO expression by dendritic cells: tolerance and tryptophan catabolism

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.12.3.313

Increased hepatitis C virus (HCV)-specific CD4+CD25 + regulatory T lymphocytes and reduced HCV-specific CD4+ T cell response in HCV-infected patients with normal versus abnormal alanine aminotransferase levels

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.12.3.313

Cell contact-dependent immunosuppression by CD4(+)CD25(+) regulatory T cells is mediated by cell surface-bound transforming growth factor beta

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.12.3.313

CD4+CD25+ T(R) cells suppress innate immune pathology through cytokine-dependent mechanisms

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.12.3.313

CD4(+)CD25(+) regulatory T cells can mediate suppressor function in the absence of transforming growth factor beta1 production and responsiveness

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.12.3.313

Activated CD4+CD25+ T cells selectively kill B lymphocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.12.3.313

Human T regulatory cells can use the perforin pathway to cause autologous target cell death

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.12.3.313

Cutting edge: contact-mediated suppression by CD4+CD25+ regulatory cells involves a granzyme B-dependent, perforin-independent mechanism

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.12.3.313

Infectious tolerance: human CD25(+) regulatory T cells convey suppressor activity to conventional CD4(+) T helper cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.12.3.313

21 January 2018

Infectious tolerance.

1 reference

https://api.crossref.org/works/10.1517%2F14728222.12.3.313

Conversion of peripheral CD4+CD25- naive T cells to CD4+CD25+ regulatory T cells by TGF-beta induction of transcription factor Foxp3

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.12.3.313

The inhibitory cytokine IL-35 contributes to regulatory T-cell function

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.12.3.313

Hepatitis C virus infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.12.3.313

Hepatitis C virus infection: when silence is deception.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.12.3.313

Immunology of hepatitis B infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.12.3.313

Hepatitis B virus immunopathogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.12.3.313

Long-term therapy with adefovir dipivoxil for HBeAg-negative chronic hepatitis B.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.12.3.313

Longitudinal analysis of CD8+ T cells specific for structural and nonstructural hepatitis B virus proteins in patients with chronic hepatitis B: implications for immunotherapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.12.3.313

Differences in HCV-specific T cell responses between chronic HCV infection and HIV/HCV co-infection.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.12.3.313

Natural regulatory T cells in infectious disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.12.3.313

Treg control of antimicrobial T cell responses

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.12.3.313

Hepatitis B virus epidemiology, disease burden, treatment, and current and emerging prevention and control measures

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.12.3.313

Asian-Pacific consensus statement on the management of chronic hepatitis B: a 2005 update

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.12.3.313

Association of CD4+CD25+Foxp3+ regulatory T cells with chronic activity and viral clearance in patients with hepatitis B.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.12.3.313

HBcAg-specific CD4+CD25+ regulatory T cells modulate immune tolerance and acute exacerbation on the natural history of chronic hepatitis B virus infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.12.3.313

Tumor necrosis factor alpha inhibits the suppressive effect of regulatory T cells on the hepatitis B virus-specific immune response

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.12.3.313

Recovery, persistence, and sequelae in hepatitis C virus infection: a perspective on long-term outcome

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.12.3.313

Differential CD4(+) and CD8(+) T-cell responsiveness in hepatitis C virus infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.12.3.313

Detection of functionally altered hepatitis C virus-specific CD4+ T cells in acute and chronic hepatitis C

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.12.3.313

Impaired effector function of hepatitis C virus-specific CD8+ T cells in chronic hepatitis C virus infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.12.3.313

Viral escape and T cell exhaustion in hepatitis C virus infection analysed using Class I peptide tetramers

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.12.3.313

The HCV core protein acts as a positive regulator of fas-mediated apoptosis in a human lymphoblastoid T cell line

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.12.3.313

Apoptosis of activated CD4+ and CD8+ T cells is enhanced by co-culture with hepatocytes expressing hepatitis C virus (HCV) structural proteins through FasL induction

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.12.3.313

Enhanced peripheral T-cell apoptosis in chronic hepatitis C virus infection: association with liver disease severity

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.12.3.313

Selective impairments in dendritic cell-associated function distinguish hepatitis C virus and HIV infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.12.3.313

Prospects for dendritic cell vaccination in persistent infection with hepatitis C virus

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.12.3.313

Regulatory T cells suppress in vitro proliferation of virus-specific CD8+ T cells during persistent hepatitis C virus infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.12.3.313

Foxp3+CD4+CD25+ T cells control virus-specific memory T cells in chimpanzees that recovered from hepatitis C

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.12.3.313

Intrahepatic virus-specific IL-10-producing CD8 T cells prevent liver damage during chronic hepatitis C virus infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.12.3.313

Hepatitis C Virus (HCV)-Specific CD8+ Cells Produce Transforming Growth Factor That Can Suppress HCV-Specific T-Cell Responses

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.12.3.313

21 January 2018

Hepatocellular carcinoma

1 reference

https://api.crossref.org/works/10.1517%2F14728222.12.3.313

Prediction of venous metastases, recurrence, and prognosis in hepatocellular carcinoma based on a unique immune response signature of the liver microenvironment.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.12.3.313

Clinicopathological study on hepatocellular carcinoma with lymphocytic infiltration.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.12.3.313

Progress in the development of immunotherapy for the treatment of patients with cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.12.3.313

Adoptive immunotherapy to lower postsurgical recurrence rates of hepatocellular carcinoma: a randomised trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.12.3.313

Regulation of tumour immunity by CD25+ T cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.12.3.313

Telomere length of in vivo expanded CD4(+)CD25 (+) regulatory T-cells is preserved in cancer patients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.12.3.313

Memory T-lymphocytes are the main population of tumor-infiltrating lymphocytes obtained from human primary liver tumors

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.12.3.313

Intratumoral balance of regulatory and cytotoxic T cells is associated with prognosis of hepatocellular carcinoma after resection.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.12.3.313

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.12.3.313

Autoimmune hepatitis, from mechanisms to therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.12.3.313

Autoimmune hepatitis in childhood: a 20-year experience.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.12.3.313

Epidemiology and pathogenesis of primary biliary cirrhosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.12.3.313

Antigen specific suppressor cell function in autoimmune chronic active hepatitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.12.3.313

Identification of hepatitis A virus as a trigger for autoimmune chronic hepatitis type 1 in susceptible individuals.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.12.3.313

Epstein-Barr virus as a trigger for autoimmune hepatitis in susceptible individuals

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.12.3.313

CD4+CD25+Foxp3+ regulatory T cells induce cytokine deprivation-mediated apoptosis of effector CD4+ T cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.12.3.313

Fas polymorphisms influence susceptibility to autoimmune hepatitis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.12.3.313

IL-2 receptor alpha deficiency and features of primary biliary cirrhosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.12.3.313

Liver-targeted and peripheral blood alterations of regulatory T cells in primary biliary cirrhosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.12.3.313

Naturally-occurring regulatory T cells are increased in inflamed portal tracts with cholangiopathy in primary biliary cirrhosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.12.3.313

IL-2 receptor alpha(-/-) mice and the development of primary biliary cirrhosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.12.3.313

Efficacy and safety of prednisolone in patients with autoimmune hepatitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.12.3.313

Synergism of cytotoxic T lymphocyte-associated antigen 4 blockade and depletion of CD25(+) regulatory T cells in antitumor therapy reveals alternative pathways for suppression of autoreactive cytotoxic T lymphocyte responses

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.12.3.313

CD25+ cell depletion hastens the onset of severe disease in collagen-induced arthritis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.12.3.313

Concurrent induction of antitumor immunity and autoimmune thyroiditis in CD4+ CD25+ regulatory T cell-depleted mice.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.12.3.313

Combination of tumor site-located CTL-associated antigen-4 blockade and systemic regulatory T-cell depletion induces tumor-destructive immune responses.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.12.3.313

Agonist anti-GITR antibody enhances vaccine-induced CD8(+) T-cell responses and tumor immunity

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.12.3.313

Treatment of advanced tumors with agonistic anti-GITR mAb and its effects on tumor-infiltrating Foxp3+CD25+CD4+ regulatory T cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.12.3.313

Stimulation of CD25(+)CD4(+) regulatory T cells through GITR breaks immunological self-tolerance

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.12.3.313

Interplay between pathogenic Th17 and regulatory T cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.12.3.313

Large-scale in vitro expansion of polyclonal human CD4(+)CD25high regulatory T cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.12.3.313

In vitro-expanded human CD4(+)CD25(+) T-regulatory cells can markedly inhibit allogeneic dendritic cell-stimulated MLR cultures

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.12.3.313

A CD4+ T-cell subset inhibits antigen-specific T-cell responses and prevents colitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.12.3.313

Reversing the defective induction of IL-10-secreting regulatory T cells in glucocorticoid-resistant asthma patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.12.3.313

Rapamycin selectively expands CD4+CD25+FoxP3+ regulatory T cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.12.3.313

In vitro generation of interleukin 10-producing regulatory CD4(+) T cells is induced by immunosuppressive drugs and inhibited by T helper type 1 (Th1)- and Th2-inducing cytokines.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.12.3.313

Pharmacological induction of tolerogenic dendritic cells and regulatory T cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.12.3.313

Dendritic cells as a tool to induce anergic and regulatory T cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.12.3.313

Therapeutic effect of CXCR3-expressing regulatory T cells on liver, lung and intestinal damages in a murine acute GVHD model.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.12.3.313

Specific recruitment of regulatory T cells in ovarian carcinoma fosters immune privilege and predicts reduced survival

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.12.3.313

Update on the current status of peptide immunotherapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.12.3.313

CD3-specific antibodies: a portal to the treatment of autoimmunity

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.12.3.313

Circulating CD4+ CD25+ regulatory T cells correlate with chronic hepatitis B infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.12.3.313

Comparable functions of plasmacytoid and monocyte-derived dendritic cells in chronic hepatitis C patients and healthy donors

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.12.3.313

Hepatic expansion of a virus-specific regulatory CD8+ T cell population in chronic hepatitis C virus infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.12.3.313

Anti-CTL-associated antigen 4: are regulatory T cells a target?

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.12.3.313

Tumor progression despite massive influx of activated CD8(+) T cells in a patient with malignant melanoma ascites

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.12.3.313

Combination therapy with anti-CTL antigen-4 and anti-4-1BB antibodies enhances cancer immunity and reduces autoimmunity

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.12.3.313

Efficient expansion of regulatory T cells in vitro and in vivo with a CD28 superagonist

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.12.3.313

Natural regulatory T cells control the development of atherosclerosis in mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.12.3.313

Cutting Edge: TGF- Signaling Is Required for the In Vivo Expansion and Immunosuppressive Capacity of Regulatory CD4+CD25+ T Cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.12.3.313